{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T22:02:40Z","timestamp":1764367360962,"version":"3.46.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    2-arachidonoylglycerol (2-AG) is an endogenous modulator of inflammatory processes. Recent studies demonstrate its key role in inflammatory cardiovascular diseases, such as atherosclerosis and left ventricular remodelling. However, whether 2-AG acts as a pro- or anti-inflammatory agent in cardiovascular inflammation is a matter of controversial debate. CD14\n                    <jats:sup>+<\/jats:sup>\n                    primary human monocytes were treated with 2-AG. Differentially expressed genes were determined by mRNA sequencing and used for bioinformatics analysis of changes in myeloid cell functions and cell signalling pathways. Additionally, we quantified cytokines and mediators involved in cardiac remodelling by multiplexing assays. Human monocytes responded to the treatment with 2-AG by inducing a pro-inflammatory cellular program. The top upregulated hallmark pathways were TNF\u03b1 signalling via the NF-\u03baB pathway, the inflammatory response and IL-6 signalling, illustrating the pro-inflammatory mode of action of 2-AG. These data were validated at the protein level in the supernatants of stimulated cells using multiplexing assays. Based on these in-vitro results, we examined blood samples from patients during acute and chronic coronary syndromes. By sampling blood from both the periphery and the culprit coronary artery, we observed a trend towards higher local concentrations of the cardiac remodelling factors Galectin-3, Osteopontin, and IP-10 in the coronary arteries of patients presenting with acute coronary syndrome compared with other groups. The levels of these remodelling factors correlate positively with 2-AG levels. Taken together, our data suggest that 2-AG acts as a pro-inflammatory agent in myocardial infarction and LV remodelling.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-28969-5","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:24:38Z","timestamp":1763724278000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unbiased assessment of 2-arachidonoylglycerol in cardiovascular inflammation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-4492","authenticated-orcid":false,"given":"Moritz","family":"N\u00f6thel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Dorer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Odainic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"R\u00fcthing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Strube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresia","family":"Weise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"L\u00fctjohann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9561-2752","authenticated-orcid":false,"given":"Susanne V.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2719-9692","authenticated-orcid":false,"given":"Julian","family":"Jehle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"28969_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1146\/annurev.immunol.021908.132557","volume":"27","author":"C Auffray","year":"2009","unstructured":"Auffray, C., Sieweke, M. H. & Geissmann, F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Ann. Rev. Immunol. 27, 669\u2013692. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132557 (2009).","journal-title":"Ann. Rev. Immunol."},{"key":"28969_CR2","doi-asserted-by":"publisher","first-page":"13886","DOI":"10.1038\/srep13886","volume":"5","author":"R Mukherjee","year":"2015","unstructured":"Mukherjee, R. et al. Non-classical monocytes display inflammatory features: Validation in sepsis and systemic lupus erythematous. Sci. Rep. 5, 13886. https:\/\/doi.org\/10.1038\/srep13886 (2015).","journal-title":"Sci. Rep."},{"key":"28969_CR3","doi-asserted-by":"publisher","first-page":"e14280","DOI":"10.1111\/eci.14280","volume":"54","author":"P Libby","year":"2024","unstructured":"Libby, P. et al. Inflammation unites diverse acute and chronic diseases. Eur. J. Clin. Invest. 54, e14280. https:\/\/doi.org\/10.1111\/eci.14280 (2024).","journal-title":"Eur. J. Clin. Invest."},{"key":"28969_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","volume":"40","author":"J Xue","year":"2014","unstructured":"Xue, J. et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274\u2013288. https:\/\/doi.org\/10.1016\/j.immuni.2014.01.006 (2014).","journal-title":"Immunity"},{"key":"28969_CR5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani, P. & Boraschi, D. From monocytes to M1\/M2 macrophages: phenotypical vs functional differentiation. Front. Immunol. 5, 514. https:\/\/doi.org\/10.3389\/fimmu.2014.00514 (2014).","journal-title":"Front. Immunol."},{"key":"28969_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00395-014-0444-7","volume":"109","author":"V Kain","year":"2014","unstructured":"Kain, V., Prabhu, S. D. & Halade, G. V. Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic Res. Cardiol. 109, 444. https:\/\/doi.org\/10.1007\/s00395-014-0444-7 (2014).","journal-title":"Basic Res. Cardiol."},{"key":"28969_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","volume":"186","author":"SB Ong","year":"2018","unstructured":"Ong, S. B. et al. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol. Ther. 186, 73\u201387. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.001 (2018).","journal-title":"Pharmacol. Ther."},{"key":"28969_CR8","doi-asserted-by":"publisher","first-page":"32660","DOI":"10.1038\/srep32660","volume":"6","author":"Y Huang","year":"2016","unstructured":"Huang, Y. et al. Abrogation of CC chemokine receptor 9 ameliorates ventricular remodeling in mice after myocardial infarction. Sci. Rep. 6, 32660. https:\/\/doi.org\/10.1038\/srep32660 (2016).","journal-title":"Sci. Rep."},{"key":"28969_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/cei.13330","volume":"198","author":"IS Toor","year":"2019","unstructured":"Toor, I. S. et al. Enhanced monocyte recruitment and delayed alternative macrophage polarization accompanies impaired repair following myocardial infarction in C57BL\/6 compared to BALB\/c mice. Clin. Exp. Immunol. 198, 83\u201393. https:\/\/doi.org\/10.1111\/cei.13330 (2019).","journal-title":"Clin. Exp. Immunol."},{"key":"28969_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1113\/expphysiol.2012.069021","volume":"98","author":"A Abbate","year":"2013","unstructured":"Abbate, A. The heart on fire: inflammasome and cardiomyopathy. Exp. Physiol. 98, 385\u2013385. https:\/\/doi.org\/10.1113\/expphysiol.2012.069021 (2013).","journal-title":"Exp. Physiol."},{"key":"28969_CR11","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.amjcard.2009.12.059","volume":"105","author":"A Abbate","year":"2010","unstructured":"Abbate, A. et al. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] pilot study). Am. J. Cardiol. 105, 1371-1377.e1371. https:\/\/doi.org\/10.1016\/j.amjcard.2009.12.059 (2010).","journal-title":"Am. J. Cardiol."},{"key":"28969_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","volume":"45","author":"MA Matter","year":"2023","unstructured":"Matter, M. A. et al. Inflammation in acute myocardial infarction: the good, the bad and the ugly. Eur. Heart J. 45, 89\u2013103. https:\/\/doi.org\/10.1093\/eurheartj\/ehad486 (2023).","journal-title":"Eur. Heart J."},{"key":"28969_CR13","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/imm.12441","volume":"144","author":"V Chiurchi\u00f9","year":"2015","unstructured":"Chiurchi\u00f9, V., Battistini, L. & Maccarrone, M. Endocannabinoid signalling in innate and adaptive immunity. Immunology 144, 352\u2013364. https:\/\/doi.org\/10.1111\/imm.12441 (2015).","journal-title":"Immunology"},{"key":"28969_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","volume":"62","author":"RG Pertwee","year":"2010","unstructured":"Pertwee, R. G. et al. International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB\u2081 and CB\u2082. Pharmacol. Rev. 62, 588\u2013631. https:\/\/doi.org\/10.1124\/pr.110.003004 (2010).","journal-title":"Pharmacol. Rev."},{"key":"28969_CR15","doi-asserted-by":"publisher","first-page":"118462","DOI":"10.1016\/j.bbamcr.2019.03.009","volume":"1867","author":"SL Puhl","year":"2020","unstructured":"Puhl, S. L. Cannabinoid-sensitive receptors in cardiac physiology and ischaemia. Biochim. Biophys. Acta Mol. Cell Res 1867, 118462. https:\/\/doi.org\/10.1016\/j.bbamcr.2019.03.009 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res"},{"key":"28969_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/oxfordjournals.jbchem.a003200","volume":"132","author":"T Sugiura","year":"2002","unstructured":"Sugiura, T. & Waku, K. Cannabinoid receptors and their endogenous ligands. J. Biochem. 132, 7\u201312. https:\/\/doi.org\/10.1093\/oxfordjournals.jbchem.a003200 (2002).","journal-title":"J. Biochem."},{"key":"28969_CR17","doi-asserted-by":"publisher","first-page":"24469","DOI":"10.1074\/jbc.M301359200","volume":"278","author":"S Kishimoto","year":"2003","unstructured":"Kishimoto, S. et al. 2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism. J. Biol. Chem. 278, 24469\u201324475. https:\/\/doi.org\/10.1074\/jbc.M301359200 (2003).","journal-title":"J. Biol. Chem."},{"key":"28969_CR18","doi-asserted-by":"publisher","first-page":"10682","DOI":"10.1038\/srep10682","volume":"5","author":"L Taylor","year":"2015","unstructured":"Taylor, L. et al. Primary macrophage chemotaxis induced by cannabinoid receptor 2 agonists occurs independently of the CB2 receptor. Sci. Rep. 5, 10682. https:\/\/doi.org\/10.1038\/srep10682 (2015).","journal-title":"Sci. Rep."},{"key":"28969_CR19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/cvr\/cvy242","volume":"115","author":"MJ Schloss","year":"2019","unstructured":"Schloss, M. J. et al. 2-Arachidonoylglycerol mobilizes myeloid cells and worsens heart function after acute myocardial infarction. Cardiovasc. Res. 115, 602\u2013613. https:\/\/doi.org\/10.1093\/cvr\/cvy242 (2019).","journal-title":"Cardiovasc. Res."},{"key":"28969_CR20","doi-asserted-by":"publisher","first-page":"e0227142","DOI":"10.1371\/journal.pone.0227142","volume":"14","author":"J Jehle","year":"2019","unstructured":"Jehle, J. et al. Endocannabinoid 2-arachidonoylglycerol is elevated in the coronary circulation during acute coronary syndrome. PLoS ONE 14, e0227142\u2013e0227142. https:\/\/doi.org\/10.1371\/journal.pone.0227142 (2019).","journal-title":"PLoS ONE"},{"key":"28969_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12265-022-10323-z","volume":"16","author":"E Avraamidou","year":"2023","unstructured":"Avraamidou, E. et al. Myeloid but not endothelial expression of the CB2 receptor promotes atherogenesis in the context of elevated levels of the endocannabinoid 2-arachidonoylglycerol. J. Cardiovasc. Transl. Res. 16, 491\u2013501. https:\/\/doi.org\/10.1007\/s12265-022-10323-z (2023).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"28969_CR22","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.1074\/jbc.M116.767384","volume":"292","author":"D Chanda","year":"2017","unstructured":"Chanda, D. et al. 2-arachidonoylglycerol ameliorates inflammatory stress-induced insulin resistance in cardiomyocytes. J. Biol. Chem. 292, 7105\u20137114. https:\/\/doi.org\/10.1074\/jbc.M116.767384 (2017).","journal-title":"J. Biol. Chem."},{"key":"28969_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2015.10.109","volume":"244","author":"N Vujic","year":"2016","unstructured":"Vujic, N. et al. Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice. Atherosclerosis 244, 9\u201321. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.10.109 (2016).","journal-title":"Atherosclerosis"},{"key":"28969_CR24","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Cambridge (Mass.)) 2, 100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141 (2021).","journal-title":"Innovation (Cambridge (Mass.))"},{"key":"28969_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cytogfr.2023.08.008","volume":"74","author":"K Na","year":"2023","unstructured":"Na, K., Oh, B. C. & Jung, Y. Multifaceted role of CD14 in innate immunity and tissue homeostasis. Cytokine Growth Factor Rev. 74, 100\u2013107. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.08.008 (2023).","journal-title":"Cytokine Growth Factor Rev."},{"key":"28969_CR26","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1042\/bj20041163","volume":"386","author":"M Gokoh","year":"2005","unstructured":"Gokoh, M. et al. 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces rapid actin polymerization in HL-60 cells differentiated into macrophage-like cells. Biochem. J. 386, 583\u2013589. https:\/\/doi.org\/10.1042\/bj20041163 (2005).","journal-title":"Biochem. J."},{"key":"28969_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1055\/s-0039-1678738","volume":"119","author":"R Guillamat-Prats","year":"2019","unstructured":"Guillamat-Prats, R., Rami, M., Herzig, S. & Steffens, S. Endocannabinoid signalling in atherosclerosis and related metabolic complications. Thromb. Haemost. 119, 567\u2013575. https:\/\/doi.org\/10.1055\/s-0039-1678738 (2019).","journal-title":"Thromb. Haemost."},{"key":"28969_CR28","doi-asserted-by":"publisher","first-page":"e0197751","DOI":"10.1371\/journal.pone.0197751","volume":"13","author":"J Jehle","year":"2018","unstructured":"Jehle, J. et al. Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE-\/- mice. PLoS ONE 13, e0197751\u2013e0197751. https:\/\/doi.org\/10.1371\/journal.pone.0197751 (2018).","journal-title":"PLoS ONE"},{"key":"28969_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/circulationaha.108.811992","volume":"119","author":"K Sugamura","year":"2009","unstructured":"Sugamura, K. et al. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation 119, 28\u201336. https:\/\/doi.org\/10.1161\/circulationaha.108.811992 (2009).","journal-title":"Circulation"},{"key":"28969_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ijcard.2020.11.027","volume":"328","author":"LJ Hou","year":"2021","unstructured":"Hou, L. J., Xie, M. Y., Ye, W. & Zhao, G. J. The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair through cannabinoid 1 (CB1) receptor. Int. J. Cardiol. 328, 176. https:\/\/doi.org\/10.1016\/j.ijcard.2020.11.027 (2021).","journal-title":"Int. J. Cardiol."},{"key":"28969_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2020.08.042","author":"J Jehle","year":"2020","unstructured":"Jehle, J. et al. The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair. Int. J. Cardiol. https:\/\/doi.org\/10.1016\/j.ijcard.2020.08.042 (2020).","journal-title":"Int. J. Cardiol."},{"key":"28969_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ijcard.2021.01.033","volume":"330","author":"J Jehle","year":"2021","unstructured":"Jehle, J. et al. Reply to \u201cThe endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair through cannabinoid 1 (CB1) receptor\u201d. Int. J. Cardiol. 330, 178. https:\/\/doi.org\/10.1016\/j.ijcard.2021.01.033 (2021).","journal-title":"Int. J. Cardiol."},{"key":"28969_CR33","doi-asserted-by":"publisher","first-page":"e0146267","DOI":"10.1371\/journal.pone.0146267","volume":"11","author":"J Jehle","year":"2016","unstructured":"Jehle, J. et al. Myeloid-specific deletion of diacylglycerol lipase \u03b1 inhibits atherogenesis in ApoE-deficient mice. PLoS ONE 11, e0146267. https:\/\/doi.org\/10.1371\/journal.pone.0146267 (2016).","journal-title":"PLoS ONE"},{"key":"28969_CR34","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/cr.2011.60","volume":"21","author":"NA Balenga","year":"2011","unstructured":"Balenga, N. A. et al. GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils. Cell Res. 21, 1452\u20131469. https:\/\/doi.org\/10.1038\/cr.2011.60 (2011).","journal-title":"Cell Res."},{"key":"28969_CR35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914 (2017).","journal-title":"N. Engl. J. Med."},{"key":"28969_CR36","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/intimm\/dxp102","volume":"21","author":"T Kouro","year":"2009","unstructured":"Kouro, T. & Takatsu, K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int. Immunol. 21, 1303\u20131309. https:\/\/doi.org\/10.1093\/intimm\/dxp102 (2009).","journal-title":"Int. Immunol."},{"key":"28969_CR37","doi-asserted-by":"publisher","first-page":"e035383","DOI":"10.1161\/jaha.124.035383","volume":"14","author":"K Lin","year":"2025","unstructured":"Lin, K. et al. Changes in blood eosinophil counts predict the death of patients with myocardial infarction after hospital discharge. J. Am. Heart Assoc. 14, e035383. https:\/\/doi.org\/10.1161\/jaha.124.035383 (2025).","journal-title":"J. Am. Heart Assoc."},{"key":"28969_CR38","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.117.006283","author":"I Ikonomidis","year":"2017","unstructured":"Ikonomidis, I. et al. Lowering interleukin-12 activity improves myocardial and vascular function compared with tumor necrosis factor-a antagonism or cyclosporine in psoriasis. Circ. Cardiovasc. Imaging https:\/\/doi.org\/10.1161\/circimaging.117.006283 (2017).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"28969_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/cvr\/cvv255","volume":"109","author":"X Kan","year":"2016","unstructured":"Kan, X. et al. Deficiency of IL-12p35 improves cardiac repair after myocardial infarction by promoting angiogenesis. Cardiovasc. Res. 109, 249\u2013259. https:\/\/doi.org\/10.1093\/cvr\/cvv255 (2016).","journal-title":"Cardiovasc. Res."},{"key":"28969_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fphar.2020.00129","volume":"11","author":"J Ye","year":"2020","unstructured":"Ye, J. et al. Roles and mechanisms of Interleukin-12 family members in cardiovascular diseases: Opportunities and challenges. Front. Pharmacol. 11, 129. https:\/\/doi.org\/10.3389\/fphar.2020.00129 (2020).","journal-title":"Front. Pharmacol."},{"key":"28969_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/cvr\/cvs142","volume":"95","author":"P Kanellakis","year":"2012","unstructured":"Kanellakis, P., Ditiatkovski, M., Kostolias, G. & Bobik, A. A pro-fibrotic role for interleukin-4 in cardiac pressure overload. Cardiovasc. Res. 95, 77\u201385. https:\/\/doi.org\/10.1093\/cvr\/cvs142 (2012).","journal-title":"Cardiovasc. Res."},{"key":"28969_CR42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1161\/hypertensionaha.115.05627","volume":"66","author":"H Peng","year":"2015","unstructured":"Peng, H. et al. Profibrotic role for Interleukin-4 in cardiac remodeling and dysfunction. Hypertension 66, 582\u2013589. https:\/\/doi.org\/10.1161\/hypertensionaha.115.05627 (2015).","journal-title":"Hypertension"},{"key":"28969_CR43","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3389\/fimmu.2019.00712","volume":"10","author":"A Doni","year":"2019","unstructured":"Doni, A. et al. The long pentraxin PTX3 as a link between innate immunity, tissue remodeling, and cancer. Front. Immunol. 10, 712. https:\/\/doi.org\/10.3389\/fimmu.2019.00712 (2019).","journal-title":"Front. Immunol."},{"key":"28969_CR44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","volume":"23","author":"C Garlanda","year":"2005","unstructured":"Garlanda, C., Bottazzi, B., Bastone, A. & Mantovani, A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Ann. Rev. Immunol. 23, 337\u2013366. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115756 (2005).","journal-title":"Ann. Rev. Immunol."},{"key":"28969_CR45","doi-asserted-by":"publisher","first-page":"1430187","DOI":"10.3389\/fimmu.2024.1430187","volume":"15","author":"S Kochumon","year":"2024","unstructured":"Kochumon, S. et al. TGF-\u03b2 and TNF-\u03b1 interaction promotes the expression of MMP-9 through H3K36 dimethylation: implications in breast cancer metastasis. Front. Immunol. 15, 1430187. https:\/\/doi.org\/10.3389\/fimmu.2024.1430187 (2024).","journal-title":"Front. Immunol."},{"key":"28969_CR46","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/circresaha.107.160408","volume":"102","author":"Y Lenga","year":"2008","unstructured":"Lenga, Y. et al. Osteopontin expression is required for myofibroblast differentiation. Circ. Res. 102, 319\u2013327. https:\/\/doi.org\/10.1161\/circresaha.107.160408 (2008).","journal-title":"Circ. Res."},{"key":"28969_CR47","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/hypertensionaha.118.11874","volume":"73","author":"E Mart\u00ednez-Mart\u00ednez","year":"2019","unstructured":"Mart\u00ednez-Mart\u00ednez, E. et al. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation. Hypertension 73, 602\u2013611. https:\/\/doi.org\/10.1161\/hypertensionaha.118.11874 (2019).","journal-title":"Hypertension"},{"key":"28969_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41423-020-00541-3","volume":"18","author":"DM Mosser","year":"2021","unstructured":"Mosser, D. M., Hamidzadeh, K. & Goncalves, R. Macrophages and the maintenance of homeostasis. Cell Mol. Immunol. 18, 579\u2013587. https:\/\/doi.org\/10.1038\/s41423-020-00541-3 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"28969_CR49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/circheartfailure.109.898114","volume":"3","author":"MA Renault","year":"2010","unstructured":"Renault, M. A. et al. Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy. Circ. Heart Fail 3, 431\u2013439. https:\/\/doi.org\/10.1161\/circheartfailure.109.898114 (2010).","journal-title":"Circ. Heart Fail"},{"key":"28969_CR50","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/circulationaha.118.035047","volume":"138","author":"K Shirakawa","year":"2018","unstructured":"Shirakawa, K. et al. IL (Interleukin)-10-STAT3-Galectin-3 axis is essential for osteopontin-producing reparative macrophage polarization after myocardial infarction. Circulation 138, 2021\u20132035. https:\/\/doi.org\/10.1161\/circulationaha.118.035047 (2018).","journal-title":"Circulation"},{"key":"28969_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092435","author":"K Shirakawa","year":"2021","unstructured":"Shirakawa, K. & Sano, M. T cell immunosenescence in aging, obesity, and cardiovascular disease. Cells https:\/\/doi.org\/10.3390\/cells10092435 (2021).","journal-title":"Cells"},{"key":"28969_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cyto.2018.04.025","volume":"110","author":"T Shimodaira","year":"2018","unstructured":"Shimodaira, T. et al. Upregulation of osteopontin expression via the interaction of macrophages and fibroblasts under IL-1b stimulation. Cytokine 110, 63\u201369. https:\/\/doi.org\/10.1016\/j.cyto.2018.04.025 (2018).","journal-title":"Cytokine"},{"key":"28969_CR53","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00384-007-0396-6","volume":"23","author":"S Yeruva","year":"2008","unstructured":"Yeruva, S., Ramadori, G. & Raddatz, D. NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int. J. Colorectal. Dis. 23, 305\u2013317. https:\/\/doi.org\/10.1007\/s00384-007-0396-6 (2008).","journal-title":"Int. J. Colorectal. Dis."},{"key":"28969_CR54","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.117.007849","author":"F Shahid","year":"2018","unstructured":"Shahid, F., Lip, G. Y. H. & Shantsila, E. Role of monocytes in heart failure and atrial fibrillation. J. Am. Heart Assoc. https:\/\/doi.org\/10.1161\/jaha.117.007849 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"28969_CR55","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/j.imbio.2012.07.001","volume":"217","author":"AM Zawada","year":"2012","unstructured":"Zawada, A. M. et al. Monocyte heterogeneity in human cardiovascular disease. Immunobiology 217, 1273\u20131284. https:\/\/doi.org\/10.1016\/j.imbio.2012.07.001 (2012).","journal-title":"Immunobiology"},{"key":"28969_CR56","doi-asserted-by":"publisher","first-page":"C797","DOI":"10.1152\/ajpcell.00330.2020","volume":"319","author":"KI Mentkowski","year":"2020","unstructured":"Mentkowski, K. I., Euscher, L. M., Patel, A., Alevriadou, B. R. & Lang, J. K. Monocyte recruitment and fate specification after myocardial infarction. Am. J. Physiol. Cell Physiol. 319, C797-c806. https:\/\/doi.org\/10.1152\/ajpcell.00330.2020 (2020).","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28969-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28969-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T22:01:55Z","timestamp":1764367315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28969-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28969"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28969-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41469"}}